Annual SG&A
$48.26 M
-$4.07 M-7.78%
31 December 2023
Summary:
AlloVir annual selling, general & administrative expenses is currently $48.26 million, with the most recent change of -$4.07 million (-7.78%) on 31 December 2023. During the last 3 years, it has risen by +$26.61 million (+122.96%). ALVR annual SG&A is now -7.78% below its all-time high of $52.33 million, reached on 31 December 2022.ALVR Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.88 M
-$1.29 M-17.94%
30 September 2024
Summary:
AlloVir quarterly selling, general & administrative expenses is currently $5.88 million, with the most recent change of -$1.29 million (-17.94%) on 30 September 2024. Over the past year, it has dropped by -$6.92 million (-54.06%). ALVR quarterly SG&A is now -58.55% below its all-time high of $14.19 million, reached on 31 December 2021.ALVR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.73 B
-$100.20 M-3.81%
30 September 2024
Summary:
AlloVir TTM selling, general & administrative expenses is currently -$2.73 billion, with the most recent change of -$100.20 million (-3.81%) on 30 September 2024. Over the past year, it has dropped by -$2.78 billion (-5584.52%). ALVR TTM SG&A is now -4838.53% below its all-time high of $54.51 million, reached on 30 September 2022.ALVR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | -54.1% | -5584.5% |
| 3 y3 years | +123.0% | -52.7% | -6373.3% |
| 5 y5 years | +1492.3% | +108.4% | -10000.0% |
ALVR Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -7.8% | +123.0% | -58.5% | at low | -282.7% | at low |
| 5 y | 5 years | -7.8% | +1492.3% | -58.5% | +108.8% | -4838.5% | at low |
| alltime | all time | -7.8% | +1492.3% | -58.5% | +229.2% | -4838.5% | at low |
AlloVir Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.88 M(-17.9%) | $34.18 M(-16.8%) |
| June 2024 | - | $7.17 M(-32.8%) | $41.10 M(-11.4%) |
| Mar 2024 | - | $10.66 M(+1.9%) | $46.41 M(-3.8%) |
| Dec 2023 | $48.26 M(-7.8%) | $10.46 M(-18.3%) | $48.26 M(-3.1%) |
| Sept 2023 | - | $12.80 M(+2.6%) | $49.81 M(-0.3%) |
| June 2023 | - | $12.48 M(-0.3%) | $49.95 M(-1.5%) |
| Mar 2023 | - | $12.51 M(+4.2%) | $50.72 M(-3.1%) |
| Dec 2022 | $52.33 M(+6.6%) | $12.01 M(-7.2%) | $52.33 M(-4.0%) |
| Sept 2022 | - | $12.95 M(-2.3%) | $54.51 M(+0.9%) |
| June 2022 | - | $13.24 M(-6.2%) | $54.01 M(+2.4%) |
| Mar 2022 | - | $14.13 M(-0.5%) | $52.74 M(+7.4%) |
| Dec 2021 | $49.08 M | $14.19 M(+14.1%) | $49.08 M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $12.44 M(+3.9%) | $43.55 M(+15.1%) |
| June 2021 | - | $11.98 M(+14.4%) | $37.83 M(+29.9%) |
| Mar 2021 | - | $10.47 M(+20.9%) | $29.11 M(+34.5%) |
| Dec 2020 | $21.65 M(+103.9%) | $8.66 M(+28.9%) | $21.65 M(+37.0%) |
| Sept 2020 | - | $6.72 M(+105.6%) | $15.80 M(+32.7%) |
| June 2020 | - | $3.27 M(+8.9%) | $11.91 M(+0.7%) |
| Mar 2020 | - | $3.00 M(+6.5%) | $11.83 M(+11.4%) |
| Dec 2019 | $10.62 M(+250.3%) | $2.82 M(-0.2%) | $10.62 M(+36.1%) |
| Sept 2019 | - | $2.82 M(-11.5%) | $7.80 M(+56.7%) |
| June 2019 | - | $3.19 M(+78.5%) | $4.98 M(+178.5%) |
| Mar 2019 | - | $1.79 M | $1.79 M |
| Dec 2018 | $3.03 M | - | - |
FAQ
- What is AlloVir annual selling, general & administrative expenses?
- What is the all time high annual SG&A for AlloVir?
- What is AlloVir annual SG&A year-on-year change?
- What is AlloVir quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for AlloVir?
- What is AlloVir quarterly SG&A year-on-year change?
- What is AlloVir TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for AlloVir?
- What is AlloVir TTM SG&A year-on-year change?
What is AlloVir annual selling, general & administrative expenses?
The current annual SG&A of ALVR is $48.26 M
What is the all time high annual SG&A for AlloVir?
AlloVir all-time high annual selling, general & administrative expenses is $52.33 M
What is AlloVir annual SG&A year-on-year change?
Over the past year, ALVR annual selling, general & administrative expenses has changed by -$4.07 M (-7.78%)
What is AlloVir quarterly selling, general & administrative expenses?
The current quarterly SG&A of ALVR is $5.88 M
What is the all time high quarterly SG&A for AlloVir?
AlloVir all-time high quarterly selling, general & administrative expenses is $14.19 M
What is AlloVir quarterly SG&A year-on-year change?
Over the past year, ALVR quarterly selling, general & administrative expenses has changed by -$6.92 M (-54.06%)
What is AlloVir TTM selling, general & administrative expenses?
The current TTM SG&A of ALVR is -$2.73 B
What is the all time high TTM SG&A for AlloVir?
AlloVir all-time high TTM selling, general & administrative expenses is $54.51 M
What is AlloVir TTM SG&A year-on-year change?
Over the past year, ALVR TTM selling, general & administrative expenses has changed by -$2.78 B (-5584.52%)